Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint AnalysisMichiel Zietse, Frederick W. Thielen, Roelof W. F. van Leeuwen et al.|JCO Oncology Practice|2025Cited by 5
The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspectiveMichiel Zietse, Carin A. Uyl‐de Groot, Ruben Malmberg et al.|BMC Health Services Research|2024Cited by 1
Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint AnalysisMichiel Zietse, Frederick W. Thielen, Roelof W. F. van Leeuwen et al.|JCO Oncology Practice|2025Cited by 0